Abstract This study seeks to test our hypothesis that transgenic induction of miR-210 in mesenchymal stem cells (MSC) simulates the pro-survival effects of ischemic preconditioning (IPC) and that engraftment of PC MSC helps in the functional recovery of ischemic heart by miR-210 transfer to host cardiomyocytes through gap junctions. miR-210 expression in MSC was achieved by IPC or nanoparticlebased transfection of miR-210 plasmid ( miR MSC) and functional recovery of the infarcted heart of rat transplanted with PC Sc MSC as controls) showed co-localization of miR-210 with gap-junctional connexin-43. miR-210 transfer to cardiomyocytes was blocked by heptanol pretreatment. Moreover, higher survival of cardiomyocytes co-cultured with PC MSC was observed with concomitant expression of CASP8AP2 as compared to cardiomyocytes co-cultured with non-PC MSC thus suggesting that miR-210 was translocated from MSC to protect host cardiomyocytes.
Introduction
MicroRNAs (miRs) are critical regulators of diverse physiological and pathological processes, including proliferation, apoptosis, differentiation, metabolism, and development [1, 2] . These regulatory effects of miRs are affected via repression or inhibition of translation of specific mRNAs involved in a specific cell function [3] . In this regard, a functional link has been established between a discrete group of hypoxia inducible factor-1α (HIF-1α-dependent hypoxia-regulated miRs (HRM) and cell survival signaling [4, 5] . More specifically, miR-210 from amongst the HRM has been identified as a universal responder to hypoxia in different cell types including endothelial cells and cancer cells [6] [7] [8] [9] . We have reported that ischemic preconditioning (IPC) of mesenchymal stem cells (MSC) with intermittent short cycles of ischemia/re-oxygenation, like any other cellular or subcellular preconditioning strategy [10] [11] [12] [13] , promoted their survival upon subsequent exposure to lethal anoxia as well as post-engraftment in the infarcted heart [14] . While elucidating the mechanism, we demonstrated that stem cell survival was mediated through HIF-1α-dependent miR-210 which targeted pro-apoptotic gene, Caspase8-associated protein-2 (Casp8ap2) [14] . In this study, we hypothesized that transfer of miRs from MSC to neighboring cardiomyocytes was the novel mechanism by which miRs affect Electronic supplementary material The online version of this article (doi:10.1007/s00109-012-0920-1) contains supplementary material, which is available to authorized users. survival under ischemic condition. We showed overexpression of miR-210 in MSC by IPC ( PC MSC) or by transfection with nanoparticle-based miR-210 plasmid ( miR MSC) contributed to functional recovery of the ischemic heart by transferring miR-210 to the cardiomyocytes through gap junctions.
Methods
In vitro data represent average of at least three independent experiments.
Isolation and culture of MSC Bone marrow-derived MSC were purified from young male Fischer-344 rats by flushing the cavity of femurs and evaluated as previously described [15] .
Preconditioning of MSC MSC were preconditioned using our optimized protocol [14] . Briefly, native MSC were seeded at 5 ×10 5 cells/ 60 mm cell culture dish. After overnight serum and glucose starvation, cells were subjected to repeated 2 cycles of 30 min anoxia with intermittent 10 min re-oxygenation in an anoxic chamber (InVivo 500, Ruskin Life Science). Subsequently, the cells were either harvested for in vitro experiments or transplantation into the infarcted heart. Nanoparticle-mediated delivery of miR-210 plasmid into MSC Plasmids containing miR-210 (pEZX-miR-210) and scrambled miRNA (pEZX-Sc) were obtained from Genecopoeia (Rockville, MD) and delivery of these plasmids into MSC was performed using polyethyleneimine (PEI) nanoparticles (Polyscience, IL) [16] . Briefly, plasmid was mixed with PEI in 1:3 ratio and incubated in Opti-MEM medium for 10 min at room temperature. The PEI-pEZX-miR complex was directly added to cells and incubated for 4 h followed by washing with PBS to remove free PEI nanoparticles. The cells were incubated for 48-72 h and used for further experimentation.
For determination of polyplex resistance to nuclease digestion, 50 μl DNase buffer (×10; Promega, WI) was mixed with 450 μl corresponding solution containing 10 μg naked plasmid DNA or PEI-DNA. After withdrawing 100 μl for the time 0.2 U DNase-I (Promega, Madison, WI) was added into the mixture and incubated at 37°C. Samples (100 μl) were collected at 30 min time intervals until 2 h after incubation. To inactivate DNase-I, all samples were treated with 10 μl of EDTA (20 mmol/l) for 10 min at 65°C.
Finally, 10 μl of heparin (4 i.u./μl) was added to each sample and incubated at 65°C for 24 h to facilitate dissociation of DNA from nanoparticles. The samples were later analyzed by electrophoresis system using 1 % agarose gel.
Isolation and detection of miR
Extraction of miRs was performed using mirVana TM miR Isolation and qRT-PCR miR Detection Kits (Ambion Diagnostics, TX) [14] . Specific miR primers provided by Ambion were used during qRT-PCR per manufacturer's instructions.
FISH for miR-210
In situ detection of miR-210 was performed on MSC plated on chamber slides or cryosections. Samples were fixed in 4 % paraformaldehyde for cell culture or acetone for cryosections at room temperature for 20 min followed by two washes in PBS. Fixed cells or 6 μm of cryosections were incubated in hybridization solution (BioChain Inc., CA) for 3 h at room temperature. Probe (3 pmol; LNA-modified and FITC-labeled oligonucleotide; Exiqon) complementary to miR-210 was hybridized to cells or tissue sections for 13-16 h at 25°C lower than predicted T m of the probe. In situ hybridization signals were detected with fluorescent microscope (BX41, Olympus, Japan).
Luciferase reporter assay
Luciferase assay was performed using the Dual-Luciferase Reporter Assay System kit (Promega), according to the manufacturer's instructions [14] .
Lactate dehydrogenase release and TUNEL assays Intracellular lactate dehydrogenase (LDH) leakage and TUNEL assays were performed using LDH Assay Kit (Diagnostic Chemicals, Charlottetown, Canada) and TMR Red (Roche Applied Science, Germany) per manufacturer's protocol [14] .
Experimental model of acute myocardial infarction and cell transplantation Our study conformed to the Guide for Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH-Publication#85-23, revised-1985) and protocol approved by the Institutional Animal Care and Use Committee, University of Cincinnati.
In vivo experiments were performed in a rat model of acute myocardial infarction using young female Fisher-344 rats [14] . Briefly, rats were anesthetized by intraperitoneal injection of ketamine/xylazine (24 and 4 mg/kg body weight, respectively). After endotracheal intubation and mechanical ventilation using Rodent Ventilator (Harvard Apparatus Model-683), the heart was exposed by left-sided minimal thoracotomy. Left MSC group-6) were injected intramyocardially at multiple sites in and around the infarct zone. The chest was closed and animals were allowed to recover. During post-operation care, Buprenex (0.1 mg/kg b.i.d.) was administered for 24 h to alleviate pain. For post-mortem studies, animals were sacrificed with an overdose of sodium pentobarbital. The heart tissue was collected and washed with PBS before use for molecular studies.
Histological and immunocytochemical analyses
For measurement of infarction size and area of fibrosis, the hearts were arrested in diastole by intravenous injection of cadmium chloride and fixed in 10 % buffered formalin. The heart was excised, cut transversely, and embedded in paraffin for Masson's trichrome staining. Immunostaining was performed as described previously [14] . The primary antibodies used were specific for α-sarcomeric actin, α-smooth muscle actin (SMA, Sigma-Aldrich, MO), vonWillebrand Factor-VIII (vWF, Dako, CA), GFP (Abcam, MA), and Ki67 (BD Pharmingen, CA). The samples were examined using fluorescence microscope (BX41, Olympus, Japan). For blood vessel density, blood vessels positive for vWF were counted in both infarct and peri-infarct areas. At least 32 high power microscopic fields (×400) each in the infarct and peri-infarct areas were randomly selected and counted in each treatment group of animals (n08 animals/group). Blood vessel density was expressed as number of vessels/ surface area (0.155 mm 2 ).
Physiological assessment of the heart function Echocardiography was performed using Compact Linear Array probe CL10-5 on HDI/5000 SONOS CT (HP) to study change in the heart function [10] .
Polymerase chain reaction
The cell and myocardial specimens from various treatment groups of animals on day 4 after cell transplantation were used for molecular studies by polymerase chain reaction (PCR) [10] . The primer sequences were: sry (forward, 5′-gaggcacaagttggctcaaca-3′; reverse, 5′-ctcctgcaaaaagggccttt-3′) and actin (forward, 5′-agccatgtacgtagccatcc-3′; reverse, 5′-ctctcagctgtggtggtgaa-3′). were electrophoresed using SDS-polyacrylamide gel and electro-immunoblotted [14] . The specific antibody used for the detection of CASP8AP2/FLASH was purchased from Santa Cruz Biotechnology, CA.
In vitro co-culture studies MSC were preconditioned as previously described [14] . 5 , labeled with DAPI prior to coculture) were seeded on 60 mm culture dishes and incubated for 24 h at 37°C in humidified atmosphere of 5%CO 2 . After cells were fixed with 4 % paraformaldehyde, TUNEL and LDH assay were performed for cell survival studies. Protocols for FISH and immunostaining were combined to detect in situ miR-210 and Cx-43 or CASP8AP2 by using miR-210 hybridization probe together with specific antibodies for Cx-43 (Abcam, Cambridge, MA) and CASP8AP2 (Santa Cruz Biotechnology, CA). miR-210 was first detected by FISH as described above. Expression of proteins was detected by immunohistochemistry [10] .
Statistical analysis
All values were expressed as mean±SE. Comparison between 2 mean values was evaluated by an unpaired Student twotailed t test and between 3 or more groups were evaluated by one-way ANOVA followed by Bonferroni post hoc analysis. Statistical significance was accepted at p<0.05.
Results

miR-210 transgene overexpression in MSC
The plasmid pEZX-miR-210 encoding for miR-210 (Online Figure-I ) was complexed with polyethyleneimine (PEI) nanoparticles at different PEI-plasmid ratios and highest transfection efficiency (34.2 %) was achieved at 3:1 PEIplasmid ratio which was used during subsequent experiments (Fig. 1a) . In vitro characterization showed that PEI protected the encapsulated plasmid from degradation for over 120 min as compared to naked plasmid which fully degraded after 30 min by DNase-I (Fig. 1b) . The expression efficiency of miR-210 in MSC transfected with PEI-pEZXmiR-210 ( miR MSC) increased in time-dependent manner for up to 9 days of observation (Fig. 1c) . We observed 8.3±1.9-fold and 8.9± 1.7-fold higher expression of miR-210 in PC MSC and miR MSC as compared to non-PC MSC and scramble (Sc) transfected MSC ( Sc MSC), respectively ( Fig. 1d ). Successful transfection of MSC for miR-210 overexpression was substantiated by fluorescent in situ hybridization (FISH) using FITC-labeled miR-210 specific probe which (Fig. 2b) . However, no significant difference in LDH leakage was observed between miR MSC and PC MSC which indicated that cytoprotective effects of IPC were simulated by transgenic overexpression of miR-210. Moreover, both strategies to enhance miR-210 expression in MSC were consistent and equally potent in protecting MSC against lethal anoxia.
In terms of molecular signaling, miR-210 overexpression led to inactivation of CASP8AP2 similar to observed in PC MSC (Fig. 2c) [14] . Western blotting confirmed CAS-P8AP2 abrogation in both PC MSC and miR MSC as compared to their respective controls under lethal anoxia (Fig. 2d) . We also observed higher caspase-8 (CASP8) in (Fig. 2e ) which was associated with significant increase in TUNEL + cells (Fig. 2f) . These data clearly showed that induction of miR-210 via IPC or by transgenic overexpression blocked CASP8AP2 under ischemic stress. (Fig. 3b) . We did not observe miR-210 expression in DMEM treated group-1 hearts. On the contrary, the LV samples from miR MSC transplanted hearts exhibited abrogation of CASP8AP2 (Fig. 3c) , thus implying a major contribution of miR-210 signaling for improved survival of miR MSC. TUNEL positivity in the periinfarct region was markedly reduced in miR MSC group-5 hearts as compared to Sc MSC group-4 thus suggesting a critical role of miR-210 in cell survival (Fig. 3d) . Fig. 4b, c (Fig. 5c) . A similar trend was also observed in maturation of the newly formed blood vessels. Arteriole density in miR MSC group-5 was 6.9±2.4 and 9.2±2.4 in the infarct and peri-infarct areas as compared to 6.8 ±2.2 and 7.3±1.9 in PC MSC group-3, respectively. However, arteriolar density in these groups was higher as compared to 5.3±1.7 and 4.7±1.8 in Sc MSC group-4 and 3.7±1.5 and 4.2 ±1.8 in non-PC MSC group-2 in the infarct and peri-infarct areas, respectively (Fig. 5d) .
Transfer of miR-210 from PC MSC and miR MSC and cardiomyocyte survival FISH was performed on cell transplanted heart sections to examine miR-210 localization using miR-210 specific FITClabeled probe (green). The results showed extensive localization of miR-210 (green) in the cardiomyocytes (visualized by actinin specific immunostaining; red) in PC MSC group-3 and miR MSC group-5 in animal hearts on day 4 after cell transplantation (Fig. 6a) . On the contrary, no miR-210 expression was observed in the cardiomyocytes from non-PC MSC group-2 and Sc MSC group-4 (Fig. 6a) (Fig. 6b) . The expression of miR-210 in animal hearts from various treatment groups was confirmed by qRT-PCR which showed multiple-fold increase in miR-210 as compared to respective controls (Fig. 3b) . Therefore, we hypothesized that therapeutic benefits of transplanted stem cells with manipulated miR-210 expression was attributed to miR-210 transfer to the cardiomyocytes.
This hypothesis was validated in an in vitro co-culture model between different treatment groups of MSC and neonatal cardiomyocytes. FISH specific for miR-210 revealed that DAPI-stained cardiomyocytes (blue nucleus, indicated by blue arrows) and non-PC MSC (without DAPI staining, indicated by red arrows) in their respective mono-cultures exhibited negligible level of miR-210 expression in comparison with PC MSC which was confirmed by RT-PCR (Fig. 6c) . However, using a co-culture system between DAPI-labeled cardiomyocytes (blue nuclei, indicated by blue arrows) and To determine cytoprotective effects of the translocated miR-210 on the cardiomyocytes in co-culture system, we exposed the co-cultured cells to lethal anoxia for 12 h. We observed that TUNEL + cardiomyocytes co-cultured with PC MSC were significantly lower than the cardiomyocytes co-cultured with non-PC MSC (Fig. 7a) . These data were substantiated by lower LDH release from cardiomyocytes cocultured with PC MSC as compared to the one co-cultured with non-PC MSC (Fig. 7b) . On the same note, transfectection with Casp8ap2 specific siRNA recapitulated the preconditioning Fig. 4 MSC manipulated effects and improved cardiomyocyte survival under lethal anoxia (p < 0.05 vs scramble transfected control cells; Fig. 7c ). Luciferase assay confirmed that Casp8ap2 was a putative target of miR-210 in cardiomyocytes (Fig. 7d) . Immunostaining showed that CASP8AP2 was markedly inhibited in the cardiomyocytes co-cultured with PC MSC and miR MSC under lethal anoxia for 12 h (Fig. 7e) . These results suggested that miR-210 delivered from PC MSC critically participated in cardiomyocyte protection in co-culture as well as in the infarcted heart. density analysis after vWF-VIII and smooth muscle specific immunostaining of the heart tissue sections at 4 weeks in different treatment groups of animals using DMEM group-1 as control.
PC MSC group-3 and miR MSC group-5 transplantation led to significantly higher capillary density as compared to Sc MSC group-4 and non-PC MSC group-2 transplantation Hypoxamir miR-210 is a universal responder to hypoxia in different cell types [6, 7, 17] . Consistent with its role in adaptive response to hypoxia, miR-210 was upregulated in placenta from patients with pre-eclampsia which was characterized by insufficient angiogenesis and consequent hypoxia [18] . Similarly, miR-210 level has been correlated with adverse clinical outcome in both breast and pancreatic cancers and with their metastatic potential [19] . Giannakakis et al. reported that miR-210 was located at the telomeric portion of the chromosome segment 11p15.5 within a minimal region of loss of heterozygosity and was confined between polymorphic marker Hras and dinucleotide repeat marker D11S1363 (∼250 kb) [20] .
Several target genes of miR-210 have been identified so far including Efna3, E2f3, Neuronal pentraxin, Rad52, and Casp8ap [7, 14, [20] [21] [22] , indicating a diverse role of miR-210 in cell cycle, DNA repair, angiogenesis, and apoptosis. Given the functional diversity of miR-210, data from tumor cells are extrapolated for manipulation of stem/progenitor cells to support their survival and functionality [6, 7, 23] . Minicircle system-based transgenic delivery of miR-210 curtailed cardiomyocyte apoptosis and supported angiogenesis via involvement of Ephrin A3 and Protein tyrosine phosphatase-1B as the target genes [23] . As our study focused on pro-survival effects of miR-210, we did not study the mechanism of improved angiogenic response observed in the animal heart after treatment with PC MSC and miR MSC. However, there is mounting evidence that native MSC secrete plethora of angiogenic growth factors as part of their paracrine activity which stimulates angiogenic as well as cytoprotective responses in the heart after MSC transplantation. Besides, these bioactive molecules secreted as part of the paracrine activity of the PC MSC or miR MSC may also alter the miR expression profile in the cardiomyocytes (i.e., miR-210) to regulate their function including survival. However, future indepth studies would be required to dissect the mechanism by which MSC modified for miR-210 expression (either by IPC or overexpression of miR-210) enhance angiogenesis in the infarcted heart as well as to identify the factors, if any, responsible for changing miR-profile of cardiomyocytes in general and that of miR-210 in particular.
Our strategy of stem cell-based delivery of exogenous miR-210 to the heart has multiple advantages over direct injection of vector encoding for miR-210. Firstly, myogenesis combined with angiogenesis is required to regenerate the infarcted heart. Angiogenesis alone would be insufficient to improve contractile function of the infarcted heart as it would not compensate for the cardiomyocyte loss subsequent to infarction. Secondly, MSC release copious amounts of pleiotropic factors as part of their paracrine activity. Thirdly, MSC with miR-210 upregulation/overexpression show better survival post-transplantation. Moreover, stem cells with miR-210 overexpression serve as reservoir for miR-210 for delivery to host cardiomyocytes in the harsh microenvironment of the infarcted heart.
There are several studies that show transfer of small molecules such as siRNA and miRs between adjacent cells via microvesicles [24] as well as through gap junctions [25] . In the same context, cardiomyocytes also exchange small RNAs through intercellular gap junctions [25] . While our manuscript was in preparation, two publications reported the role of gapjunctional translocation of miRs between adjacent cells [26, 27] . Using a co-culture system between breast cancer cells and bone marrow stromal cells, miRs including miR-127, -197, -222, and -223 have been implicated for role in cell proliferation by targeting Cxcl12 and these miRs were transported from bone marrow stroma to breast cancer cells via gap junctions [28] . Similarly, in both in vitro and in vivo assay systems, miR-499 was actually translocated from cardiomyocytes into cardiac stem cells to repress Rod1 and Sox6 and promoted their cardiogenic differentiation [27] . These findings substantiate our hypothesis that such mechanism also exists between cardiomyocytes and stem cells with miR-210 overexpression to regulate Casp8ap2 target gene expression in the cardiomyocytes. CASP8AP2 is a multifunctional protein which is not only involved in apoptosis but also influences S-phase progression and transcriptional regulation [29, 30] . We have identified Casp8ap2 as a putative target of miR-210, abrogation of which significantly improved stem cell survival under lethal anoxia [14] . While elucidating the effect of concomitant activation of HIF-1α-dependent miRs, i.e., miR-017 and miR-210, we have recently shown that Casp8ap2 specific siRNA interference, either alone or together with PDCD10 (a putative target of miR-107), replicated the cytoprotective effects of IPC and led to improved survival of the cells lethal anoxia [31] .
An interesting finding of our present study was that pretreatment of stem cells with heptanol, an inhibitor of Cx-43 pores, blocked miR-210 transfer between cardiomyocytes co-cultured with miR MSC or PC MSC which indicated that miR-210 transfer occurred through gap junctions. However, this did not exclude the possibility that miR-210 transfer or induction also occurred by other mechanisms and therefore warranted in-depth studies for systematic analysis of the contribution of each of these different mechanisms of miR transfer. In the same context, future studies would be required to exclude the possible exchange of some as yet undefined factor/s between co-cultured cardiomyocytes and miR MSC or PC MSC that accentuated miR-210 induction or transfer in the cardiomyocytes. More importantly, induction of miR-210 in stem cells improved their survival under ischemic stress and translocation of miR-210 reduced TUNEL positivity in recipient cardiomyocytes. Transplantation of miR MSC in the infarcted heart increased their survival as demonstrated by higher sry-gene expression, increased number of Ki67 + proliferating cells and lower TUNEL positivity as compared to Sc MSC. Higher sry-gene expression in PC MSC group-3 and miR MSC group-5 observed may be attributed to pro-survival effects of miR-210 combined with proliferative activity of the surviving cells in the heart. Taken together, direct transfer of miRs from MSC to the cardiomyocytes is a possible new strategy in cell-based therapy for the ischemic myocardium. Further in-depth mechanistic studies in this regard are however warranted to explore this intriguing possibility. Although, our data provide evidence regarding myogenic differentiation of the transplanted stem cells with higher miR-210 expression, future studies should exclusively determine the role of miR-210 in cardiac differentiation of stem cells.
In conclusion, stem cell-based miR-210 delivery to the infarcted heart is novel and effective strategy to preserve the LV function through multiple mechanisms. The induction of pro-survival miRs not only addresses the issue of donor cell survival, the direct cell-to-cell transfer of the "repair" miRs from donor cells to host cardiomyocytes also lead to repair of the damaged heart.
